BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9069738)

  • 1. Ready or not.
    Maklebust J; Margolis D
    Adv Wound Care; 1996; 9(4):6. PubMed ID: 9069738
    [No Abstract]   [Full Text] [Related]  

  • 2. It is time for physicians to embrace cost-effectiveness and cost utility analysis research in the treatment of spinal pain.
    Dagenais S; Haldeman S; Polatin PB
    Spine J; 2005; 5(4):357-60. PubMed ID: 15996604
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic value of out-of-hospital emergency care: a structured literature review.
    Lerner EB; Maio RF; Garrison HG; Spaite DW; Nichol G
    Ann Emerg Med; 2006 Jun; 47(6):515-24. PubMed ID: 16713777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
    Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
    Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing preferences for health outcomes in economic evaluations.
    Tosteson AN
    J Rheumatol Suppl; 2003 Dec; 68():15-8. PubMed ID: 14725249
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis as a measure of value.
    Garber AM
    Tecnologica; 1996 Jan; ():1, 3-6, 9-10. PubMed ID: 10170483
    [No Abstract]   [Full Text] [Related]  

  • 7. Our second responsibility in trauma care. A new clause in the social contract.
    Eiseman B
    Bull Am Coll Surg; 1994 Mar; 79(3):23-35. PubMed ID: 10132606
    [No Abstract]   [Full Text] [Related]  

  • 8. Handling uncertainty when performing economic evaluation of healthcare interventions.
    Briggs AH; Gray AM
    Health Technol Assess; 1999; 3(2):1-134. PubMed ID: 10448202
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of quality-adjusted life-years in cost-effectiveness studies.
    Sculpher M
    Allergy; 2006 May; 61(5):527-30. PubMed ID: 16629779
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness and quality-of-life analysis of physician-staffed helicopter emergency medical services.
    Ringburg AN; Polinder S; Meulman TJ; Steyerberg EW; van Lieshout EM; Patka P; van Beeck EF; Schipper IB
    Br J Surg; 2009 Nov; 96(11):1365-70. PubMed ID: 19847879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A wound care equation for the new millennium.
    Hess CT; Salcido R
    Adv Wound Care; 1999 May; 12(4):151-2. PubMed ID: 10655795
    [No Abstract]   [Full Text] [Related]  

  • 13. [The cost per year of life gained: trends and internal contradictions].
    van Dam J
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):441; author reply 441-2. PubMed ID: 17343145
    [No Abstract]   [Full Text] [Related]  

  • 14. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
    Hoerger TJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption costs and earnings during added years of life - a reply to Nyman.
    Gandjour A
    Health Econ; 2006 Mar; 15(3):315-7; discussion 319-22. PubMed ID: 16444762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medical-economic analysis: a necessary complement to "evidence based medicine"].
    Wasserfallen JB
    Rev Med Suisse Romande; 2001 Apr; 121(4):265-8. PubMed ID: 11400397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-utility analysis; uncertainties restrict applicability].
    de Neeling JN
    Ned Tijdschr Geneeskd; 2004 May; 148(22):1106-10. PubMed ID: 15198066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESRD as a window into America's cost crisis in health care.
    Knauf F; Aronson PS
    J Am Soc Nephrol; 2009 Oct; 20(10):2093-7. PubMed ID: 19729435
    [No Abstract]   [Full Text] [Related]  

  • 19. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The principles of economic analysis.
    Sperry RJ; Naslund M; Baum N
    Cost Qual Q J; 1999 Mar; 5(1):7-11. PubMed ID: 10351763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.